Alto Neuroscience (ANRO) Prepaid Assets (2023 - 2026)
Alto Neuroscience (ANRO) reported Prepaid Assets of $5.4 million for Q1 2026, up 23221.74% on a YoY basis from N/an in Q1 2025, and up 334.68% sequentially from $1.2 million in Q4 2025.
Alto Neuroscience (ANRO) Prepaid Assets (2023 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 4 years of Prepaid Assets data on file, last reported at $5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 23221.74% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 23221.74% YoY), and the FY2025 full-year result was $1.2 million, up 11.37% from the prior year.
- Prepaid Assets climbed to $5.4 million in Q1 2026, from $1.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.4 million in Q1 2026 to a low of $23000.0 in Q1 2025.
- A 4-year average of $2.1 million and a median of $2.0 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets plunged 99.05% in 2025 and soared 23221.74% in 2026, its largest moves.
- Tracing ANRO's Prepaid Assets over 4 years: stood at $2.8 million in 2023, then sank by 61.03% to $1.1 million in 2024, then climbed by 11.37% to $1.2 million in 2025, then surged by 334.68% to $5.4 million in 2026.
- Business Quant data shows ANRO's Prepaid Assets at $5.4 million in Q1 2026, $1.2 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Alto Neuroscience | 881.86 Mn | 881.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.36 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.63 Mn |
| Jun 30, 2025 | 2.26 Mn |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.83 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.42 Mn |
| Dec 31, 2023 | 2.84 Mn |